Tirzepatide belongs to a class of drugs called GLP-1 receptor agonists. These drugs mimic the action of a hormone called
glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels by enhancing insulin production and reducing the amount of glucose produced by the liver, potentially helpful in addressing blood sugar, particularly in patients with Type 2 Diabetes.
